Eastern Cooperative Oncology Group

Boston, Massachusetts 02215

3 studies enrolling now · 45 studies all time

What they study most

AIDS-related Kaposi Sarcoma, Adenocarcinoma of the Bladder, Adenocarcinoma of the Colon, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Lung, Adenocarcinoma of the Prostate, Adenocarcinoma of the Rectum, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Unresectable Gastric Cancer, Anaplastic Large Cell Lymphoma, Anemia

Studies at this site

• Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer — Recruiting now
• Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer — Recruiting now
• Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer — Recruiting now
• Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Running, not enrolling
• A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) — Running, not enrolling
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — Stopped early
• Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer — Completed
• Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma — Stopped early
• Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma — Completed
• A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer — Completed
• Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer — Stopped early
• Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant — Stopped early
• Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer — Completed
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer — Completed
• Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma — Completed
• Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy — Completed
• Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer — Completed
• Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma — Completed
• Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium — Stopped early
• Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer — Completed
• Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed
• Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Lenalidomide and Prednisone in Treating Patients With Myelofibrosis — Completed
• Bevacizumab or Cetuximab And Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Pacreatic Cancer That Has Been Completely Removed By Surgery — Completed
• Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast Cancer — Completed
• Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer — Completed
• Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer — Completed
• Ixabepilone in Treating Patients With Metastatic Prostate Cancer — Completed
• Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Completed
• Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection — Stopped early
• Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma — Completed
• CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) — Completed
• Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck — Completed
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma — Completed
• Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer — Completed
• A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer — Completed
• Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer — Completed
• Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer — Completed
• Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer — Completed
• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck — Completed
• Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer — Completed
• Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated — Completed
• Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma — Completed
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer — Completed